New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 21, 2014
10:01 EDTSQBK, SLMVV, NAVIV, ATEN, PCRX, AHP, TWOU, ATO, AGTCOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: 2U (TWOU) initiated with a Buy at Compass Point... A10 Networks (ATEN) initiated with a Buy at Citigroup... Applied Genetic (AGTC) initiated with a Buy at Cantor... Ashford Hospitality Prime (AHP) initiated with a Hold at Deutsche Bank... Atmos Energy (ATO) initiated with a Neutral at JPMorgan... Navient (NAVIV) initiated with a Buy at Goldman... Pacira Pharmaceuticals (PCRX) initiated with a Buy at BofA/Merrill... Puma Biotechnology (PBYI) initiated with a Buy at Citigroup... Sallie Mae Bank (SLMVV) initiated with a Neutral at Goldman... Square 1 Financial (SQBK) initiated with a Market Perform at Keefe Bruyette.
News For TWOU;ATEN;AGTC;AHP;NAVIV;ATO;PCRX;SLMVV;SQBK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 2, 2015
09:22 EDTPCRXOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Amira Nature Foods (ANFI), up 8.6%... Stratasys (SSYS), up 3.6%... Magnum Hunter (MHR), up 3%. ALSO HIGHER: Mavenir Systems (MVNR), up 19.1% after Mitel (MITL) agrees to acquire Mavenir Systems for $560M... Athersys (ATHX), up 19.7% following license agreement and collaboration with Chugai... OHR Pharmaceutical (OHRP), up 11.4% following additional positive data from OHR-102 IMPACT study... NXP Semiconductors (NXPI), up 14% following merger agreement with Freescale Semiconductor (FSL). Freescale Semiconductor is up 9.1%... Mast Therapeutics (MSTX), up 7.7% following positive results from Vepoloxamer study. DOWN AFTER EARNINGS: JinkoSolar (JKS), down 4.7%... Scorpio Tankers (STNG), down 4.5%. ALSO LOWER: Lumber Liquidators (LL), down 24.2% following CBS' 60 Minutes says that the company is linked to health and safety violations... Aruba Networks (ARUN), down 1.7% after HP (HPQ) confirms deal to acquire Aruba Networks for $24.67... Pacira Pharmaceuticals (PCRX), down 14.4% after receiving complete response letter from FDA for sNDA in use of Exparel... 500.com (WBAI), down 14.4% after announcing that temporary suspension will adversely impact financial results.
06:41 EDTSQBKPacWest Bancorp, Square 1 Financial to merge in transaction valued at $849M
Subscribe for More Information
06:33 EDTPCRXPacira receives complete response letter from FDA for sNDA in use of Exparel
Subscribe for More Information
February 26, 2015
17:12 EDTAHPAshford Hospitality Prime reports Q4 FFO 21c, may not compare to consensus (12c)
Subscribe for More Information
16:21 EDTTWOU2U sees FY15 adjusted EPS ($50c)-($46c), consensus (49c)
Subscribe for More Information
16:20 EDTTWOU2U sees Q1 adjusted EPS (11c)-(10c), consensus (14c)
Subscribe for More Information
16:19 EDTTWOU2U reports Q4 adjusted EPS (5c), consensus (7c)
Reports Q4 revenue $30.8M, consensus $30.14M.
10:00 EDTPCRXOn The Fly: Analyst Downgrade SummaryStarz
Subscribe for More Information
07:43 EDTPCRXPacira downgraded at BofA/Merrill
Subscribe for More Information
06:17 EDTPCRXPacira downgraded to Underperform from Neutral at BofA/Merrill
Subscribe for More Information
February 25, 2015
07:26 EDTPCRXPacira price target raised to $135 from $111 at Brean Capital
Subscribe for More Information
February 24, 2015
06:43 EDTPCRXPacira sees FY15 Exparel revenue $310M-$330M
Subscribe for More Information
06:42 EDTPCRXPacira reports Q4 non-GAAP EPS 35c, consensus 28c
Reports Q4 revenue $61.8M, consensus $62.12M
February 23, 2015
08:33 EDTTWOU2U should report beat and raise results, says Pacific Crest
Pacific Crest expects 2U to report beat and raise results, as the firm thinks the Street's estimates do not adequately reflect the revenue boost that the company typically receives from the back to school season. The firm recommends buying the stock.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use